Siemens Healthineers AG (ETR:SHL) Receives €42.44 Average PT from Analysts

Shares of Siemens Healthineers AG (ETR:SHL) have been given a consensus rating of “Hold” by the sixteen analysts that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and six have assigned a buy rating to the company. The average 1-year price target among analysts that have covered the stock in the last year is €42.44 ($47.69).

SHL has been the subject of several research reports. Kepler Capital Markets set a €40.00 ($44.94) price target on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research note on Tuesday, April 21st. Barclays set a €38.00 ($42.70) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research note on Friday, May 15th. Nord/LB set a €52.00 ($58.43) target price on shares of Siemens Healthineers and gave the stock a “buy” rating in a research note on Tuesday, July 14th. JPMorgan Chase & Co. set a €37.60 ($42.25) target price on shares of Siemens Healthineers and gave the stock a “sell” rating in a research note on Wednesday, July 1st. Finally, Royal Bank of Canada set a €45.00 ($50.56) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research note on Tuesday, July 21st.

ETR:SHL opened at €43.96 ($49.39) on Tuesday. The company has a fifty day simple moving average of €43.08 and a two-hundred day simple moving average of €40.70. The company has a market cap of $43.93 billion and a price-to-earnings ratio of 28.38. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 67.03. Siemens Healthineers has a 52 week low of €28.50 ($32.02) and a 52 week high of €47.27 ($53.11).

Siemens Healthineers Company Profile

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Read More: Fundamental Analysis – How It Helps Investors

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.